<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17626076</PMID><DateCompleted><Year>2007</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>81</Volume><Issue>19</Issue><PubDate><Year>2007</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice.</ArticleTitle><Pagination><StartPage>10310</StartPage><EndPage>10315</EndPage><MedlinePgn>10310-5</MedlinePgn></Pagination><Abstract><AbstractText>In this study, we sought to determine whether intratypic and intertypic cross-reactivity protected against enterovirus 71 (EV71) infection in a murine infection model. We demonstrate that active immunization of 1-day-old mice with avirulent EV71 strain or coxsackie A16 virus (CA16) by the oral route developed anti-EV71 antibodies with neutralizing activity (1:16 and 1:2, respectively). Splenocytes from both EV71- and CA16-immunized mice proliferated upon EV71 or CA16, but not coxsackie B3 virus (CB3), antigen stimulation. Immunized mice became more resistant to virulent EV71 strain challenge than nonimmunized mice. There was an increase in the percentage of activated splenic T cells and B cells in the immunized mice 2 days after EV71 challenge. The CA16 immune serum reacted with EV71 antigens in an enzyme-linked immunosorbent assay and neutralized EV71 but not CB3 or poliovirus at a titer of 1:4. Passive immunization with the CA16 immune serum reduced the clinical score, diminished the organ viral load, and increased the survival rate of mice upon EV71 challenge. CB3 neither shared in vitro cross-reactivity with EV71 nor provided in vivo protection after both active and passive immunization. These results illustrated that live vaccine is feasible for EV71 and that intertypic cross-reactivity of enteroviruses may provide a way to determine the prevalence of EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Te-Chia</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Institute of Basic Medical Sciences, Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ya-Fang</ForeName><Initials>YF</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yi-Ping</ForeName><Initials>YP</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jen-Ren</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ching-Chuan</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shih-Min</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Huan-Yao</ForeName><Initials>HY</Initials></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Ih-Jen</ForeName><Initials>IJ</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chun-Keung</ForeName><Initials>CK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2007</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007116" MajorTopicYN="N">Immunization, Passive</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>7</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>11</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>7</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2008</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17626076</ArticleId><ArticleId IdType="pmc">PMC2045469</ArticleId><ArticleId IdType="doi">10.1128/JVI.00372-07</ArticleId><ArticleId IdType="pii">JVI.00372-07</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>CDC. 2005. Epidemiology bulletin, vol. 21. CDC, Taiwan, Republic of China.</Citation></Reference><Reference><Citation>Chan, Y. F., and S. AbuBakar. 2004. Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg. Infect. Dis. 10:1468-1470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3320397</ArticleId><ArticleId IdType="pubmed">15496251</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh, W., A. Bouzidi, G. Alm, P. Wattre, and D. Hober. 2001. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro. J. Gen. Virol. 82:1899-1907.</Citation><ArticleIdList><ArticleId IdType="pubmed">11457996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. F., M. H. Chang, B. L. Chiang, and S. T. Jeng. 2006. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 24:2944-2951.</Citation><ArticleIdList><ArticleId IdType="pubmed">16448730</ArticleId></ArticleIdList></Reference><Reference><Citation>Girn, J., M. Kavoosi, and J. Chantler. 2002. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J. Gen. Virol. 83:351-358.</Citation><ArticleIdList><ArticleId IdType="pubmed">11807228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara, A., Tagaya, I., and T. Yoneyama. 1978. Common antigen between coxsackievirus A16 and enterovirus 71. Microbiol. Immunol. 22:81-88.</Citation><ArticleIdList><ArticleId IdType="pubmed">209293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho, M. 2000. Enterovirus 71: the virus, its infections, and outbreaks. J. Microbiol. Immunol. Infect. 33:205-216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11269363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung, G. D. 1994. Hsiung's diagnostic virology. Yale University Press, New Haven, CT.</Citation></Reference><Reference><Citation>Juhela, S., H. Hyoty, M. Lonnrot, M. Roivainen, O. Simell, and J. Ilonen. 1998. Enterovirus infections and enterovirus specific T-cell responses in infancy. J. Med. Virol. 54:226-232.</Citation><ArticleIdList><ArticleId IdType="pubmed">9515773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto, C., M. Kurokawa, and H. Ochiai. 2002. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J. Mol. Cell. Cardiol. 34:1227-1238.</Citation><ArticleIdList><ArticleId IdType="pubmed">12392896</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, M. L., Y. P. Lee, Y. F. Wang, H. Y. Lei, C. C. Liu, S. M. Wang, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen, and C. K. Yu. 2005. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86:3263-3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukashev, A. N. 2005. Role of recombination in evolution of enteroviruses. Rev. Med. Virol. 15:157-167.</Citation><ArticleIdList><ArticleId IdType="pubmed">15578739</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn, P. C. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91-107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste, M. S., K. Maher, and M. A. Pallansch. 2004. Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J. Virol. 78:855-867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC368751</ArticleId><ArticleId IdType="pubmed">14694117</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste, M. S., S. Penaranda, K. Maher, and M. A. Pallansch. 2004. Complete genome sequences of all members of the species human enterovirus A. J. Gen. Virol. 85:1597-1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">15166444</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegrist, C. A. 2001. Neonatal and early life vaccinology. Vaccine 19:3331-3346.</Citation><ArticleIdList><ArticleId IdType="pubmed">11348697</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlig, H., and R. Dernick. 1988. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies. Virology 163:214-217.</Citation><ArticleIdList><ArticleId IdType="pubmed">2831657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J. R., Y. C. Tuan, H. P. Tsai, J. J. Yan, C. C. Liu, and I. J. Su. 2002. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J. Clin. Microbiol. 40:10-15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC120096</ArticleId><ArticleId IdType="pubmed">11773085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, S. M., H. Y. Lei, M. C. Huang, J. M. Wu, C. T. Chen, J. N. Wang, J. R. Wang, and C. C. Liu. 2005. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr. Pulmonol. 39:219-223.</Citation><ArticleIdList><ArticleId IdType="pubmed">15635619</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, S. M., H. Y. Lei, M. C. Huang, L. Y. Su, H. C. Lin, C. K. Yu, J. L. Wang, and C. C. Liu. 2006. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J. Clin. Virol. 37:47-52.</Citation><ArticleIdList><ArticleId IdType="pubmed">16861032</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. F., C. T. Chou, H. Y. Lei, C. C. Liu, S. M. Wang, J. J. Yan, I. J. Su, J. R. Wang, T. M. Yeh, S. H. Chen, and C. K. Yu. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 78:7916-7924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, C. N., Y. C. Lin, C. Fann, N. S. Liao, S. R. Shih, and M. S. Ho. 2001. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20:895-904.</Citation><ArticleIdList><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, J. J., I. J. Su, P. F. Chen, C. C. Liu, C. K. Yu, and J. R. Wang. 2001. Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J. Med. Virol. 65:331-339.</Citation><ArticleIdList><ArticleId IdType="pubmed">11536241</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, C. K., C. C. Chen, C. L. Chen, J. R. Wang, C. C. Liu, J. J. Yan, and I. J. Su. 2000. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J. Biomed. Sci. 7:523-528.</Citation><ArticleIdList><ArticleId IdType="pubmed">11060501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>